SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-007342
Filing Date
2024-03-08
Accepted
2024-03-08 16:18:39
Documents
1
Period of Report
2024-03-07

Document Format Files

Seq Description Document Type Size
1 form4-03082024_090327.html 4  
1 form4-03082024_090327.xml 4 4415
  Complete submission text file 0001415889-24-007342.txt   6007
Mailing Address 485 ROUTE 1 SOUTH BUILDING F, SUITE 320 ISELIN NJ 08830
Business Address 485 ROUTE 1 SOUTH BUILDING F, SUITE 320 ISELIN NJ 08830 6096193990
Outlook Therapeutics, Inc. (Issuer) CIK: 0001649989 (see all company filings)

IRS No.: 383982704 | State of Incorp.: DE | Fiscal Year End: 0930
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O OUTLOOK THERAPEUTICS, INC. 4260 US ROUTE 1 MONMOUTH JUNCTION NJ 08852
Business Address
Huang Andong (Reporting) CIK: 0001815678 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37759 | Film No.: 24734623